2023 Q1 Form 10-K Financial Statement
#000149315223010166 Filed on March 31, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $5.199M | $6.996M | $25.73M |
YoY Change | -10.1% | -17.08% | -1.99% |
Cost Of Revenue | $4.488M | $6.009M | $22.23M |
YoY Change | -11.18% | -19.21% | -3.26% |
Gross Profit | $711.0K | $987.0K | $3.494M |
YoY Change | -2.6% | -1.2% | 6.98% |
Gross Profit Margin | 13.68% | 14.11% | 13.58% |
Selling, General & Admin | $933.0K | $1.057M | $4.400M |
YoY Change | -28.51% | 4.34% | 23.35% |
% of Gross Profit | 131.22% | 107.09% | 125.93% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $7.000K | $9.000K | $32.00K |
YoY Change | -22.22% | -83.93% | -55.56% |
% of Gross Profit | 0.98% | 0.91% | 0.92% |
Operating Expenses | $933.0K | $1.057M | $4.400M |
YoY Change | -28.51% | 4.34% | 23.35% |
Operating Profit | -$222.0K | -$70.00K | -$906.0K |
YoY Change | -61.39% | 400.0% | 201.0% |
Interest Expense | $44.00K | $29.00K | $171.0K |
YoY Change | 76.0% | -62.82% | -27.23% |
% of Operating Profit | |||
Other Income/Expense, Net | $13.00K | $223.0K | |
YoY Change | -105.8% | -97.68% | |
Pretax Income | -$192.0K | -$28.00K | -$569.0K |
YoY Change | -65.22% | -96.7% | -106.41% |
Income Tax | $3.000K | $53.00K | $170.0K |
% Of Pretax Income | |||
Net Earnings | -$195.0K | -$81.00K | -$739.0K |
YoY Change | -64.8% | -89.3% | -109.36% |
Net Earnings / Revenue | -3.75% | -1.16% | -2.87% |
Basic Earnings Per Share | $0.00 | $0.00 | |
Diluted Earnings Per Share | $0.00 | $0.00 | $0.00 |
COMMON SHARES | |||
Basic Shares Outstanding | 300.0M shares | 300.0M shares | |
Diluted Shares Outstanding | 300.0M shares | 300.0M shares |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $364.0K | $227.0K | $227.0K |
YoY Change | 427.54% | 845.83% | 845.83% |
Cash & Equivalents | $364.0K | $227.0K | $227.0K |
Short-Term Investments | |||
Other Short-Term Assets | $396.0K | $430.0K | $430.0K |
YoY Change | 59.04% | 29.91% | 29.91% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $924.0K | $2.619M | $6.337M |
Other Receivables | $6.553M | $6.470M | $6.470M |
Total Short-Term Assets | $10.90M | $13.46M | $13.46M |
YoY Change | -15.51% | -5.44% | -5.44% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $19.00K | $26.00K | $26.00K |
YoY Change | -53.66% | -46.94% | -46.94% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $19.00K | $26.00K | $26.00K |
YoY Change | -53.66% | -46.94% | -46.94% |
TOTAL ASSETS | |||
Total Short-Term Assets | $10.90M | $13.46M | $13.46M |
Total Long-Term Assets | $19.00K | $26.00K | $26.00K |
Total Assets | $10.91M | $13.49M | $13.49M |
YoY Change | -15.63% | -5.59% | -5.59% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $443.0K | $698.0K | $698.0K |
YoY Change | -47.7% | -42.07% | -42.07% |
Accrued Expenses | $232.0K | $339.0K | $1.320M |
YoY Change | -70.22% | -16.09% | -35.07% |
Deferred Revenue | $176.0K | $176.0K | |
YoY Change | 0.0% | ||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $924.0K | $2.619M | $2.619M |
YoY Change | -41.89% | 176.85% | 176.85% |
Total Short-Term Liabilities | $2.438M | $4.819M | $4.819M |
YoY Change | -40.25% | -1.21% | -1.21% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.438M | $4.819M | $4.819M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $2.438M | $4.819M | |
YoY Change | -40.25% | -1.21% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $7.726M | $7.921M | |
YoY Change | -8.53% | ||
Common Stock | $750.0K | $750.0K | |
YoY Change | 0.0% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $8.476M | $8.671M | $8.671M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $10.91M | $13.49M | $13.49M |
YoY Change | -15.63% | -5.59% | -5.59% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$195.0K | -$81.00K | -$739.0K |
YoY Change | -64.8% | -89.3% | -109.36% |
Depreciation, Depletion And Amortization | $7.000K | $9.000K | $32.00K |
YoY Change | -22.22% | -83.93% | -55.56% |
Cash From Operating Activities | $1.842M | -$1.463M | -$1.427M |
YoY Change | -408.03% | 1194.69% | -156.97% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $8.000K | $9.000K | |
YoY Change | -900.0% | -228.57% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$8.000K | -$9.000K | |
YoY Change | 700.0% | 28.57% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -$1.705M | 571.0K | $1.639M |
YoY Change | -364.75% | 1579.41% | -164.43% |
NET CHANGE | |||
Cash From Operating Activities | $1.842M | -1.463M | -$1.427M |
Cash From Investing Activities | -8.000K | -$9.000K | |
Cash From Financing Activities | -$1.705M | 571.0K | $1.639M |
Net Change In Cash | $137.0K | -900.0K | $203.0K |
YoY Change | 204.44% | 1025.0% | -541.3% |
FREE CASH FLOW | |||
Cash From Operating Activities | $1.842M | -$1.463M | -$1.427M |
Capital Expenditures | $8.000K | $9.000K | |
Free Cash Flow | $1.842M | -$1.471M | -$1.436M |
YoY Change | -408.54% | 1213.39% | -157.17% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000034285 | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
usd | |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
usd | |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | RLBY |
Subsequent Events
SubsequentEvents
|
usd | |
CY2021Q4 | RLBY |
Subsequent Events
SubsequentEvents
|
usd | |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
usd | |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
usd | |
CY2021 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
usd | |
CY2022 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
usd | |
CY2022 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
usd | |
CY2022 | RLBY |
Loss On Impairment Of Goodwill And Other Intangible Assets
LossOnImpairmentOfGoodwillAndOtherIntangibleAssets
|
usd | |
CY2022 | RLBY |
Gain On Forgiveness Of Ppp Loan Payable
GainOnForgivenessOfPppLoanPayable
|
usd | |
CY2022 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
usd | |
CY2022 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
usd | |
CY2022 | RLBY |
Ppp Loan And Interest Forgiveness
PppLoanAndInterestForgiveness
|
usd | |
CY2021 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
usd | |
CY2021Q4 | RLBY |
Deferred Tax Liabilities Cash To Accrual
DeferredTaxLiabilitiesCashToAccrual
|
usd | |
CY2021Q4 | RLBY |
Deferred Tax Assets Liabilities Interest Limitation
DeferredTaxAssetsLiabilitiesInterestLimitation
|
usd | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
usd | |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
usd | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
CY2022 | RLBY |
Income Tax Reconciliation Forgiveness Of Ppp Loan Federal
IncomeTaxReconciliationForgivenessOfPPPLoanFederal
|
usd | |
CY2022 | RLBY |
Effective Income Tax Rate Reconciliation Forgiveness Of Ppp Loan Federal
EffectiveIncomeTaxRateReconciliationForgivenessOfPPPLoanFederal
|
pure | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.002 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.002 | pure |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
000-07092 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
RELIABILITY INCORPORATED | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
TX | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
75-0868913 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
12124 Skylark Rd | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Clarksburg | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MD | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
20871 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
(202) | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
965-1100 | |
CY2022 | dei |
Security12b Title
Security12bTitle
|
Common Stock | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
2329030 | usd |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
300000000 | shares |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
820 | |
CY2022 | dei |
Auditor Name
AuditorName
|
Ramirez Jimenez International CPAs | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Irvine, California | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
227000 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
24000 | usd |
CY2022Q4 | us-gaap |
Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
|
6337000 | usd |
CY2021Q4 | us-gaap |
Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
|
6405000 | usd |
CY2022Q4 | RLBY |
Retention Credit Receivable
RetentionCreditReceivable
|
1219000 | usd |
CY2021Q4 | RLBY |
Retention Credit Receivable
RetentionCreditReceivable
|
2494000 | usd |
CY2022Q4 | us-gaap |
Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
|
5251000 | usd |
CY2021Q4 | us-gaap |
Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
|
4985000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
430000 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
331000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
13464000 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
14239000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
26000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
49000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
13490000 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
14288000 | usd |
CY2022Q4 | RLBY |
Factoring Liability Current
FactoringLiabilityCurrent
|
2619000 | usd |
CY2021Q4 | RLBY |
Factoring Liability Current
FactoringLiabilityCurrent
|
946000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
698000 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1205000 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
339000 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
404000 | usd |
CY2022Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
981000 | usd |
CY2021Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
1629000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
176000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
176000 | usd |
CY2022Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
6000 | usd |
CY2021Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
517000 | usd |
CY2021Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
1000 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4819000 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4878000 | usd |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
300000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
300000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
300000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
300000000 | shares |
CY2022Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
750000 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
750000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
7921000 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
8660000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8671000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9410000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
13490000 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
14288000 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
25725000 | usd |
CY2021 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
26246000 | usd |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
22231000 | usd |
CY2021 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
22980000 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
3494000 | usd |
CY2021 | us-gaap |
Gross Profit
GrossProfit
|
3266000 | usd |
CY2022 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
4400000 | usd |
CY2021 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3567000 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-906000 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-301000 | usd |
CY2022 | RLBY |
Interest Income From Related Parties
InterestIncomeFromRelatedParties
|
232000 | usd |
CY2021 | RLBY |
Interest Income From Related Parties
InterestIncomeFromRelatedParties
|
274000 | usd |
CY2022 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
53000 | usd |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
171000 | usd |
CY2021 | us-gaap |
Interest Expense
InterestExpense
|
39000 | usd |
CY2021 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
688000 | usd |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
223000 | usd |
CY2021 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
9631000 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-569000 | usd |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
8877000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
170000 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
984000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-739000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7893000 | usd |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
300000000 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
300000000 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
300000000 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
300000000 | shares |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1517000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7893000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9410000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9410000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-739000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-739000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8671000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8671000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-739000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7893000 | usd |
CY2022 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
32000 | usd |
CY2021 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
72000 | usd |
CY2021 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
4000 | usd |
CY2022 | us-gaap |
Interest Income Other
InterestIncomeOther
|
232000 | usd |
CY2021 | us-gaap |
Interest Income Other
InterestIncomeOther
|
274000 | usd |
CY2021 | RLBY |
Loss On Impairment Of Goodwill And Other Intangible Assets
LossOnImpairmentOfGoodwillAndOtherIntangibleAssets
|
-688000 | usd |
CY2021 | RLBY |
Gain On Forgiveness Of Ppp Loan Payable
GainOnForgivenessOfPppLoanPayable
|
-5250000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-39000 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-464000 | usd |
CY2022 | RLBY |
Increase Decrease In Retention Credit Receivable
IncreaseDecreaseInRetentionCreditReceivable
|
-1304000 | usd |
CY2021 | RLBY |
Increase Decrease In Retention Credit Receivable
IncreaseDecreaseInRetentionCreditReceivable
|
2494000 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
99000 | usd |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
42000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-507000 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
270000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
-648000 | usd |
CY2021 | us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
939000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-65000 | usd |
CY2021 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
28000 | usd |
CY2021 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-6000 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-1000 | usd |
CY2021 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-4000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-511000 | usd |
CY2021 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
225000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1427000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
2505000 | usd |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
9000 | usd |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
7000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-9000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-7000 | usd |
CY2022 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
1673000 | usd |
CY2021 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-2053000 | usd |
CY2021 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
37000 | usd |
CY2022 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
-34000 | usd |
CY2021 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
-454000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1639000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-2544000 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
203000 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-46000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
24000 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
70000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
227000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
24000 | usd |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
150000 | usd |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
39000 | usd |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
681000 | usd |
CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
969000 | usd |
CY2021 | RLBY |
Ppp Loan And Interest Forgiveness
PppLoanAndInterestForgiveness
|
5250000 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-906000 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-301000 | usd |
CY2022Q4 | us-gaap |
Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
|
5251000 | usd |
CY2022 | us-gaap |
Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
|
4327000 | usd |
CY2022 | us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
1000000 | usd |
CY2022Q4 | RLBY |
Retention Credit Receivable
RetentionCreditReceivable
|
1219000 | usd |
CY2022 | us-gaap |
Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
|
500000 | usd |
CY2022 | us-gaap |
Fiscal Period
FiscalPeriod
|
<p id="xdx_845_eus-gaap--FiscalPeriod_zVGOWm3tDZHl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zgY7KR6nKJLd">Fiscal Year</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s fiscal year is from January 1<sup>st</sup> through December 31<sup>st</sup>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_845_eus-gaap--UseOfEstimates_zdFhc9nlxze8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zC6awNa5Njvf">Management Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements and related disclosures are prepared in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The Company must make estimates and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates are used for, but not limited to revenue recognition, allowances for doubtful accounts, recoverability of notes receivable, useful lives for depreciation and amortization, loss contingencies, and the valuation allowances for deferred income taxes. Actual results may be materially different from those estimated. In making its estimates, the Company considers the current economic and legislative environment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
49000 | usd |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
112000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
26000 | usd |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zSEEKsVmADa3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zMuTw7yg02Ub">Concentration of Credit Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022, the Company’s top 10 clients generated over <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientsMember_z3GlFB0KahY9" title="Concentration of credit risk percentage">86</span>% of the revenue. A sizable portion of our business tends to come from three or four clients. In 2022, Client A (inclusive of its Client B division) (“Client AA”), Client C, and Client D accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientCAndDMember_zcgIXjWR5aPf" title="Concentration of credit risk percentage">58.8</span>% of total revenue. Client AA accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientAMember_zUCkn8CoAEOb" title="Concentration of credit risk percentage">26.3</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientAMember_zN8dgZEIvVJ7" title="Concentration of credit risk percentage">27.9</span>% of revenue in 2022 and 2021, respectively. Client AA comprised approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientAAMember_ziDYJTQMcgya" title="Concentration of credit risk percentage">47.4</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientAAMember_zmVUZ20OQnS3" title="Concentration of credit risk percentage">41.1</span>% of the accounts receivable balance as of December 31, 2022 and 2021, respectively. Client C delivered <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientCMember_z2HBwhfEU5th" title="Concentration of credit risk percentage">19.6</span>% of revenue in 2022 compared to <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientCMember_z9PvpMSVo3p6" title="Concentration of credit risk percentage">14.9</span>% in 2021. Client D accounted for approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientDMember_zzDWy1JTJiI6" title="Concentration of credit risk percentage">12.9</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientDMember_zLTiADQaRPNb" title="Concentration of credit risk percentage">14.5</span>% of our total revenues for the years ended December 31, 2022 and 2021, respectively. Client D comprised approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientDMember_zpt0w5dvNT51" title="Concentration of credit risk percentage">22.4</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ClientDMember_zazAkwBAyZ6e" title="Concentration of credit risk percentage">32.9</span>% of accounts receivable as of December 31, 2022 and 2021, respectively. <span id="xdx_90A_eus-gaap--ConcentrationRiskBenchmarkDescription_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__us-gaap--OtherCustomerMember_zEiosQiJlIDj" title="Concentration risk, benchmark description">No other client exceeded 10% of revenues.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially subject the Company to concentrations of credit risk, are primarily cash and accounts receivable. The Company performs continuing credit evaluations of its customers and does not require collateral. The Company has not experienced significant losses related to receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
176000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
176000 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
32000 | usd |
CY2021 | us-gaap |
Depreciation
Depreciation
|
72000 | usd |
CY2021 | us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
688000 | usd |
CY2021 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
34000 | usd |
CY2021 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
170000 | usd |
CY2022 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
518000 | usd |
CY2021Q4 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
0 | usd |
CY2022Q4 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
0 | usd |
CY2022 | us-gaap |
Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
|
0 | usd |
CY2021 | us-gaap |
Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
|
0 | usd |
CY2022 | us-gaap |
Advertising Expense
AdvertisingExpense
|
25000 | usd |
CY2021 | us-gaap |
Advertising Expense
AdvertisingExpense
|
23000 | usd |
CY2022 | us-gaap |
Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
|
less than a 50% likelihood of being sustained. | |
CY2022 | us-gaap |
Income Tax Examination Description
IncomeTaxExaminationDescription
|
The Company’s tax years are subject to examination for 2019 and forward for U.S. Federal tax purposes and for 2018 and forward for state tax purposes. | |
CY2022Q4 | us-gaap |
Billed Contract Receivables
BilledContractReceivables
|
3131000 | usd |
CY2021Q4 | us-gaap |
Billed Contract Receivables
BilledContractReceivables
|
4646000 | usd |
CY2022Q4 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
587000 | usd |
CY2021Q4 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
813000 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2619000 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
946000 | usd |
CY2022Q4 | us-gaap |
Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
|
6337000 | usd |
CY2021Q4 | us-gaap |
Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
|
6405000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
164000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
161000 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
138000 | usd |
CY2019Q4 | us-gaap |
Goodwill
Goodwill
|
518000 | usd |
CY2019Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
240000 | usd |
CY2021Q4 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
518000 | usd |
CY2021Q4 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
170000 | usd |
CY2022Q4 | RLBY |
Accrued Vendor Costs Current
AccruedVendorCostsCurrent
|
199000 | usd |
CY2021Q4 | RLBY |
Accrued Vendor Costs Current
AccruedVendorCostsCurrent
|
182000 | usd |
CY2022Q4 | us-gaap |
Accrued Insurance Current
AccruedInsuranceCurrent
|
124000 | usd |
CY2021Q4 | us-gaap |
Accrued Insurance Current
AccruedInsuranceCurrent
|
176000 | usd |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
16000 | usd |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
46000 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
339000 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
404000 | usd |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
113000 | usd |
CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
743000 | usd |
CY2022 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
57000 | usd |
CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
241000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
170000 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
984000 | usd |
CY2022Q4 | RLBY |
Deferred Tax Liabilities Employee Accrual
DeferredTaxLiabilitiesEmployeeAccrual
|
134000 | usd |
CY2021Q4 | RLBY |
Deferred Tax Liabilities Employee Accrual
DeferredTaxLiabilitiesEmployeeAccrual
|
16000 | usd |
CY2022Q4 | RLBY |
Deferred Tax Liabilities Accrued Workers Compensationother
DeferredTaxLiabilitiesAccruedWorkersCompensationother
|
-8000 | usd |
CY2021Q4 | RLBY |
Deferred Tax Liabilities Accrued Workers Compensationother
DeferredTaxLiabilitiesAccruedWorkersCompensationother
|
-18000 | usd |
CY2021Q4 | RLBY |
Deferred Tax Liabilities State Deduction
DeferredTaxLiabilitiesStateDeduction
|
-41000 | usd |
CY2022Q4 | RLBY |
Deferred Tax Assets Liabilities Interest Limitation
DeferredTaxAssetsLiabilitiesInterestLimitation
|
-44000 | usd |
CY2022Q4 | RLBY |
Deferred Tax Assets Liabilities Federal And State Nol
DeferredTaxAssetsLiabilitiesFederalAndStateNOL
|
-152000 | usd |
CY2021Q4 | RLBY |
Deferred Tax Assets Liabilities Federal And State Nol
DeferredTaxAssetsLiabilitiesFederalAndStateNOL
|
-94000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
14000 | usd |
CY2022Q4 | RLBY |
Deferred Tax Liabilities Property Plant And Equipments
DeferredTaxLiabilitiesPropertyPlantAndEquipments
|
22000 | usd |
CY2021Q4 | RLBY |
Deferred Tax Liabilities Property Plant And Equipments
DeferredTaxLiabilitiesPropertyPlantAndEquipments
|
-9000 | usd |
CY2022Q4 | RLBY |
Deferred Income Taxes Net
DeferredIncomeTaxesNet
|
375000 | usd |
CY2021Q4 | RLBY |
Deferred Income Taxes Net
DeferredIncomeTaxesNet
|
160000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
375000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
160000 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-119000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
1874000 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
6000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.01 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
165000 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.018 | pure |
CY2021 | RLBY |
Income Tax Reconciliation Forgiveness Of Ppp Loan Federal
IncomeTaxReconciliationForgivenessOfPPPLoanFederal
|
-1095000 | usd |
CY2021 | RLBY |
Effective Income Tax Rate Reconciliation Forgiveness Of Ppp Loan Federal
EffectiveIncomeTaxRateReconciliationForgivenessOfPPPLoanFederal
|
-0.123 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
14000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-0.025 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
-45000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
|
0.078 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
215000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.378 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-13000 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-99000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.174 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
53000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
170000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.299 | pure |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
984000 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.1103 | pure |
CY2021Q4 | RLBY |
Final Estimated Portion Payment
FinalEstimatedPortionPayment
|
300000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
1000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
284000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
5000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
232000 | usd |
CY2022 | RLBY |
Reserve Interest Percentage
ReserveInterestPercentage
|
0.10 | pure |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2619000 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
946000 | usd |
CY2022 | us-gaap |
Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
|
169000 | usd |
CY2021 | us-gaap |
Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
|
71000 | usd |
CY2019Q3 | us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
402500 | usd |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
300000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
300000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
300000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
300000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
CY2020Q2 | RLBY |
Reimbursement
Reimbursement
|
83000 | usd |
CY2022 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
5000000 | usd |
CY2022 | RLBY |
Average Sale Price Percentage
AverageSalePricePercentage
|
1.20 | pure |
CY2022 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
4 | integer |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
25725000 | usd |
CY2021 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
26246000 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
25725000 | usd |
CY2021 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
26246000 | usd |